Sponsor study identifier
interventional
14
1 country
1
Study Start
July 29, 2024
Actual (reported)Primary Completion
April 30, 2025
Actual (reported)Study Completion
April 30, 2025
Actual (reported)Eye Movement Desensitization and Reprocessing therapy is a time-limited trauma-response therapy that treats symptoms of stress that result disturbing life experiences. Eye Movement Desensitization and Reprocessing therapy has been used to treat trauma-related symptoms for people living with HIV. People living with HIV tend to experience higher psychiatric morbidity rates of depression, anxiety, and post-traumatic stress symptoms than the general population. However, even with case studies of Eye Movement Desensitization and Reprocessing therapy on people living with HIV, there is no definitive protocol for the clinician as they navigate the therapy. This study aims to assess the feasibility and acceptability of delivering an Eye Movement Desensitization and Reprocessing therapy protocol tailored for people living with HIV and trauma. 20 people living with HIV will be recruited to participate in an eight-week Eye Movement Desensitization and Reprocessing therapy. The therapy will be focused on assessing the viability of an Eye Movement Desensitization and Reprocessing protocol that is specified for people living with HIV.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
April 30, 2025
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
July 29, 2024
Actual (reported)November 20, 2024
Actual (reported)December 12, 2024
Actual (reported)April 30, 2025
Actual (reported)April 30, 2025
Actual (reported)Recruitment of PLHIV and trauma to participate in EMDR
Recruitment will be assessed by the rate of enrollment (participants/month).
9 months
Study Retention
Retention will be assessed by counting the number of participants who are retained throughout the study.
10 months
Engagement
Engagement will be assessed by counting the number of EMDR sessions attended by participants
10 months
Intervention Fidelity
Fidelity will be assessed by the EMDR Fidelity Rating Scale
10 months
Program Completion
10 months
Data Collection Completion
10 months
Intervention Evaluation
10 months
The intervention involves an eight-week program that details a specific EMDR protocol and questionnaire for people living with HIV. The EMDR sessions occur once a week for eight weeks under the supervision of the investigator.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Vanderbilt University Medical Center
Nashville, Tennessee, 37232, United States
14 participants (actual enrollment reported by the registry).
First Submitted
November 20, 2024
First Posted
December 12, 2024
Study Start
July 29, 2024
Actual (reported)Contact the study team to confirm eligibility.
Primary Completion
April 30, 2025
Actual (reported)Study Completion
April 30, 2025
Actual (reported)Last Updated
June 24, 2025
Record last verified: 2025-06
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: